<IPO>Argo Biopharma Considering HK IPO to Raise $2.34B: Rumor
Chinese biotech company, Argo Biopharma, is considering an IPO in Hong Kong to raise approx. US$3...
Chinese biotech company, Argo Biopharma, is considering an IPO in Hong Kong to raise approx. US$300 million (equivalent to about $2.34 billion), Reuters' IFR quoted sources as saying.
Argo Biopharma was established in April 2021, and is a clinical-stage biotechnology company committed to developing next-generation siRNA therapeutics to provide better treatment options for patients worldwide, according to the company's website.
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.